Review
©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Feb 15, 2015; 6(1): 67-79
Published online Feb 15, 2015. doi: 10.4239/wjd.v6.i1.67
Table 1 Characteristics of the relevant autoantibodies in type 1 diabetes[
125 - 134 ]
Antigen Sensitivity Specificity Percent at onset Annotation ICA Islet cells 70% 99% 70%-90% Single positivity similar predictive; in combination ≥ 3 increasing risk to approximately 90%; age independent GADA Glutamic acid decarboxylase (65 kDa) 65%-75% 99% 70%-80% IA2A Tyrosine phosphatase-related islet antigen 2 50%-90% 99% 50%-70% IAA Proinsulin/insulin 74% 99% 30%-50% Inverse correlation with age; measurement prior to insulin therapy required ZnT8 C terminal domain of the zinc transporter 8 65%-75% 99% 60%-80% Declines rapidly after onset of T1D
Table 2 Involvement of family members of patients with type 1 diabetes[
5 ,
27 ,
135 ]
Affected family member Presence of T1D First degree relative (general) 5%-6% Mother 2% Father 7% Monozygotic twin 30%-50% Dizygotic twin 6%-10%
Table 3 Prevalence of associated autoimmunity in patients with type 1 diabetes[
15 ,
55 ,
56 ,
60 ,
97 ,
100 ,
136 - 143 ]
Associated disease Patients with type 1 diabetes General population Prevalence of organ-specific Abs Overt disease Prevalence of organ-specific Abs Overt disease Type 1 diabetes ICA in 85%-90% 100% ICA in 1%-3 % 0.1%-1.0% Hashimoto’s thyroiditis TPO Abs in 15%-30% 10%-20% TPO Abs in 2%-10% 0.5%-9.0% Graves’ disease TSH-R Abs in 1%-18% 3%-6% TSH-R Abs in 1%-2% 0.1%-2.0% Addison’s disease 21-OH Abs in 0.7%-2.0% 0.5%-0.8% 21-OH Abs in 0.6% 0.005%-0.140% Autoimmune hypophysitis and/or hypopituitarism Pituitary Abs in 3.6% 0.4%-0.9% Pituitary Abs in 0.5% 0.24%-0.80% Autoimmune type A gastritis and pernicious anemia Gastric parietal cell Abs in 13%-25% 5%-10% (2%-6%) Gastric parietal cell Abs in 2.5%-12.0% 2% (0.15%-1.00%) Celiac disease Transglutaminase Abs in 8%-12% 1%-9% Transglutaminase Abs in 0.5%-1.0% 0.50%
Table 4 Odds ratio of susceptibility genes for autoimmune endocrinopathies[
117 ,
144 - 160 ]
T1D HT GD AD HLA-DR3 3.5 3.7 2-4 5 MICA 1.6 2.5 2 7 PTPN22 1.8 1.6 1.6 1.5 CTLA-4 1.5 5 1.5 1.8
Table 5 Polyglandular autoimmune syndromes[
13 ,
68 ,
78 ,
161 - 166 ]
PAS Type IPAS Type II- IVIPEX Onset Childhood Adulthood Infancy Incidence < 1:100000/yr 1–2:100000/yr Extremely rare Male/Female ratio 3:04 1:03 Male >> Female Genetics Monogenetic (AIRE) Polygenetic X-linked (FOXP3) Autoantibodies Anti-interferon-α/ω antibodies 100%, additional Abs Organ-specific Abs depending on the autoimmune components ANA (42%) SSA (25%) TG Abs (25%) Prevalence of T1D 2%-33% 40%-60% 80% Additional autoimmune endocrine components Hypoparathyroidism (80%-85%) Addison’s disease (60%-70%) Hypogonadism (12%) Autoimmune thyroid disease (10%) Autoimmune thyroid disease (70%-75%) Addison’s disease (40%-50%) Hypoparathyroidism (0%-5%) Hypogonadism (0%-3%) Hypopituitarism (0%-2%) Autoimmune thyroid disease (25%) Concomitant non-endocrine diseases Mucocutaneous candidiasis (70%-80%); autoimmune hepatitis; autoimmune gastritis; alopecia areata; vitiligo; keratoconjunctivitis Autoimmune gastritis; pernicious anemia; neurodermitis; alopecia areata; myasthenia gravis; systemic lupus erythematosus; rheumatoid arthritis; autoimmune hepatitis Malabsorption; autoimmune skin diseases; multiple sclerosis